[ET Net News Agency, 4 October 2024] NT PHARMA (01011) rose 43.4% to HK$0.38, breaking
above the 100-D SMA of HK$0.273.
It hits an intra-day high of HK$0.4, hitting an 1-month high, and an intra-day low of
HK$0.247. The total shares traded was 6.32 million, with a value of HK$1.74m. The active
buy/sell ratio is 62:38, with net buying turnover of HK$419,120. J.P. MORGAN BRO (HK)
accounts for greatest net responsive buying turnover of HK$31,487, with volume weighted
average price of HK$0.259. FUTU SEC INT'L accounts for greatest net responsive selling
turnover of HK$352,380, with volume weighted average price of HK$0.257. The stock has
risen a combined 85.4% over the past 5 consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 0.380 % Chg +43.40%
High 0.400 Low 0.247
Shares Tr 6.32m Turnover 1.74m
10-D SMA 0.248 %H.V 92.325
20-D SMA 0.240 VWAP 0.275
50-D SMA 0.270 RSI14 74.406
---------------------------------
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is
62:38, with net buying turnover of HK$419,120, rising a combined 85.4% over the past 5
consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
NT PHARMA (01011) 0.38 +43.40
TRAD CHI MED (00570) 4.40 +0.23
CMS (00867) 9.72 +3.18
CSPC PHARMA (01093) 6.60 +6.11
SINO BIOPHARM (01177) 4.01 +3.89
FOSUN PHARMA (02196) 16.22 +4.38
WUXI APPTEC (02359) 68.65 +14.13
CHINARES PHARMA (03320) 6.45 +4.88
HANSOH PHARMA (03692) 21.10 +0.48
PHARMARON (03759) 17.70 +11.32
-----------------------------------------------
(ed)